[HTML][HTML] The role of ARF family proteins and their regulators and effectors in cancer progression: a therapeutic perspective
The Adenosine diphosphate-Ribosylation Factor (ARF) family belongs to the RAS
superfamily of small GTPases and is involved in a wide variety of physiological processes …
superfamily of small GTPases and is involved in a wide variety of physiological processes …
Rho GTPases and related signaling complexes in cell migration and invasion
X Guan, X Guan, C Dong, Z Jiao - Experimental cell research, 2020 - Elsevier
Cell migration and invasion play an important role in the development of cancer. Cell
migration is associated with several specific actin filament–based structures, including …
migration is associated with several specific actin filament–based structures, including …
Drugging the small GTPase pathways in cancer treatment: promises and challenges
N Prieto-Dominguez, C Parnell, Y Teng - Cells, 2019 - mdpi.com
Small GTPases are a family of low molecular weight GTP-hydrolyzing enzymes that cycle
between an inactive state when bound to GDP and an active state when associated to GTP …
between an inactive state when bound to GDP and an active state when associated to GTP …
Optimizing size exclusion chromatography for extracellular vesicle enrichment and proteomic analysis from clinically relevant samples
The field of extracellular vesicle (EV) research has rapidly expanded in recent years, with
particular interest in their potential as circulating biomarkers. Proteomic analysis of EVs from …
particular interest in their potential as circulating biomarkers. Proteomic analysis of EVs from …
FGF19 amplification reveals an oncogenic dependency upon autocrine FGF19/FGFR4 signaling in head and neck squamous cell carcinoma
The fibroblast growth factor 19 gene FGF19 has previously been reported to be amplified in
several cancer types and encodes for a key autocrine signaler known to promote …
several cancer types and encodes for a key autocrine signaler known to promote …
Analysis of circulating breast cancer cell heterogeneity and interactions with peripheral blood mononuclear cells
HM Brechbuhl, K Vinod‐Paul, AE Gillen… - Molecular …, 2020 - Wiley Online Library
For solid tumors, extravasation of cancer cells and their survival in circulation represents a
critical stage of the metastatic process that lacks complete understanding. Gaining insight …
critical stage of the metastatic process that lacks complete understanding. Gaining insight …
The Golgi complex in disease and therapy
F Zappa, M Failli, MA De Matteis - Current opinion in cell biology, 2018 - Elsevier
The Golgi complex occupies a strategic position in the endomembrane system and acts not
only as a key trafficking and sorting station and a vital biosynthetic center for glycoproteins …
only as a key trafficking and sorting station and a vital biosynthetic center for glycoproteins …
Targeting small GTPases: emerging grasps on previously untamable targets, pioneered by KRAS
G Yin, J Huang, J Petela, H Jiang, Y Zhang… - … and Targeted Therapy, 2023 - nature.com
Abstract Small GTPases including Ras, Rho, Rab, Arf, and Ran are omnipresent molecular
switches in regulating key cellular functions. Their dysregulation is a therapeutic target for …
switches in regulating key cellular functions. Their dysregulation is a therapeutic target for …
Towards resolving the pro-and anti-tumor effects of the aryl hydrocarbon receptor
S Narasimhan, E Stanford Zulick, O Novikov… - International journal of …, 2018 - mdpi.com
We have postulated that the aryl hydrocarbon receptor (AHR) drives the later, more lethal
stages of some cancers when chronically activated by endogenous ligands. However, other …
stages of some cancers when chronically activated by endogenous ligands. However, other …
KLHL21, a novel gene that contributes to the progression of hepatocellular carcinoma
L Shi, W Zhang, F Zou, L Mei, G Wu, Y Teng - BMC cancer, 2016 - Springer
Background Hepatocellular carcinoma (HCC) has very high prevalence and associated-
mortality. However, targeted therapies that are currently used in clinical practice for HCC …
mortality. However, targeted therapies that are currently used in clinical practice for HCC …